A new daily weight loss pill can help patients with type 2 diabetes lose more weight and better control their blood sugar ...

Trial results published in the Lancet suggest the new appetite suppressing pill by pharmaceutical giant Eli Lilly worked best for patients with Type 2 diabetes, with two positive outcomes ...

Eli Lilly on Thursday released new data from a head-to-head trial of its experimental weight-loss pill, orforglipron, and rival Novo Nordisk's oral semaglutide in diabetes patients, giving a more ...

Losing weight with the help of a prescription weight loss drug continues to increase in popularity. According to recent KFF polls, about one in eight U.S. adults takes a GLP-1 medication for ...

Comparing six diets, a new study found that the DASH diet in particular showed the strongest link to helping lower cognitive ...

Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these ...

Doctors call Wegovy’s new weight loss pill a game changer in the fight against obesity, but some experts are urging patients to be cautious. Just weeks after hitting the market, nearly 200,000 people ...

Novo Nordisk stock fell over 16% Monday after it said its next-generation weight loss drug didn't meet its primary target.

Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be ...

Fish oil capsules sit on pharmacy shelves with quiet confidence. They promise heart strength, sharper thinking, and calmer ...

The Allurion gastric balloon can be swallowed in a 15-minute office visit and lead to a weight loss of up to 14 percent in 4 ...